| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.076 | 0.02 |
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.02 |
| mRNA | KIN001-244 | GDSC1000 | pan-cancer | AAC | 0.068 | 0.03 |
| mRNA | XMD15-27 | GDSC1000 | pan-cancer | AAC | 0.073 | 0.03 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.074 | 0.03 |
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.078 | 0.03 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | -0.087 | 0.03 |
| mRNA | YL54 | CTRPv2 | pan-cancer | AAC | -0.084 | 0.03 |
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.067 | 0.04 |
| mRNA | TAK-715 | GDSC1000 | pan-cancer | AAC | 0.066 | 0.04 |